A Minnesota law that takes effect July 1 imposes annual fees of $55,000 on opioid manufacturers as a means of funding efforts to combat the addiction crisis.
State Rep. Dave Baker (R), a co-sponsor of the law, said he expects other states to follow suit with similar legislation. Many state lawmakers were excited about Minnesota’s approach during a meeting of the National Conference of State Legislators in May, he said.
“Some states thought this was pretty cutting edge,” Baker said.
The business license fees are expected to generate $20 million a year. The funds will help counties deal with ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.